Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Progesterone | 4 | 2018 | 663 | 1.480 |
Why?
|
| Glutamine | 4 | 2022 | 196 | 1.410 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 130 | 0.790 |
Why?
|
| Fatty Acids | 1 | 2025 | 351 | 0.770 |
Why?
|
| Biomarkers, Tumor | 3 | 2019 | 1559 | 0.730 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 196 | 0.640 |
Why?
|
| Breast Neoplasms | 4 | 2018 | 2582 | 0.570 |
Why?
|
| Ephrin-A2 | 1 | 2017 | 3 | 0.560 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2018 | 67 | 0.560 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 438 | 0.560 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2021 | 267 | 0.540 |
Why?
|
| Carrier Proteins | 1 | 2021 | 1011 | 0.470 |
Why?
|
| Phosphoproteins | 1 | 2017 | 420 | 0.470 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 714 | 0.460 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 579 | 0.450 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 576 | 0.430 |
Why?
|
| Receptor, EphA2 | 3 | 2020 | 28 | 0.430 |
Why?
|
| TATA-Box Binding Protein | 1 | 2013 | 31 | 0.410 |
Why?
|
| RANK Ligand | 1 | 2013 | 51 | 0.400 |
Why?
|
| STAT5 Transcription Factor | 1 | 2013 | 85 | 0.400 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2013 | 160 | 0.390 |
Why?
|
| Protein Folding | 1 | 2013 | 214 | 0.380 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 413 | 0.360 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1757 | 0.350 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 2313 | 0.330 |
Why?
|
| Glutaminase | 2 | 2022 | 17 | 0.330 |
Why?
|
| Progesterone | 3 | 2018 | 430 | 0.320 |
Why?
|
| Epithelial Cells | 1 | 2013 | 869 | 0.300 |
Why?
|
| Signal Transduction | 4 | 2019 | 4468 | 0.290 |
Why?
|
| Tumor Microenvironment | 2 | 2025 | 626 | 0.280 |
Why?
|
| Cell Line, Tumor | 3 | 2025 | 3483 | 0.270 |
Why?
|
| Mice | 9 | 2025 | 17585 | 0.250 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2025 | 167 | 0.250 |
Why?
|
| Animals | 11 | 2025 | 33120 | 0.250 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2025 | 12 | 0.230 |
Why?
|
| Everolimus | 1 | 2025 | 48 | 0.230 |
Why?
|
| Neoplasm Metastasis | 1 | 2025 | 686 | 0.190 |
Why?
|
| Endothelial Cells | 1 | 2025 | 505 | 0.180 |
Why?
|
| Protein Binding | 2 | 2016 | 1661 | 0.170 |
Why?
|
| Phospholipase C gamma | 1 | 2020 | 28 | 0.160 |
Why?
|
| Heterografts | 1 | 2021 | 189 | 0.160 |
Why?
|
| Neoplasm Transplantation | 1 | 2021 | 361 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 2 | 2019 | 985 | 0.160 |
Why?
|
| MTOR Associated Protein, LST8 Homolog | 1 | 2019 | 1 | 0.150 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2020 | 220 | 0.150 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2019 | 30 | 0.150 |
Why?
|
| Female | 8 | 2025 | 67915 | 0.150 |
Why?
|
| Observational Studies as Topic | 1 | 2018 | 96 | 0.140 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2017 | 6 | 0.140 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2017 | 37 | 0.140 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 4409 | 0.140 |
Why?
|
| Breast | 1 | 2018 | 208 | 0.130 |
Why?
|
| Gastroenteritis | 1 | 2019 | 307 | 0.130 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 253 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 632 | 0.130 |
Why?
|
| Ephrin-A1 | 1 | 2016 | 2 | 0.120 |
Why?
|
| Estrogens | 1 | 2018 | 424 | 0.120 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 2311 | 0.120 |
Why?
|
| Cell Proliferation | 3 | 2019 | 2389 | 0.120 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2015 | 67 | 0.120 |
Why?
|
| Humans | 9 | 2025 | 126089 | 0.110 |
Why?
|
| Muscle Proteins | 1 | 2017 | 397 | 0.110 |
Why?
|
| Trans-Activators | 1 | 2017 | 674 | 0.110 |
Why?
|
| ErbB Receptors | 1 | 2015 | 285 | 0.110 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 1096 | 0.110 |
Why?
|
| Stromal Cells | 1 | 2015 | 300 | 0.100 |
Why?
|
| Progestins | 1 | 2013 | 42 | 0.100 |
Why?
|
| Prolactin | 1 | 2013 | 111 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 620 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2015 | 826 | 0.100 |
Why?
|
| Protein Structure, Secondary | 1 | 2013 | 237 | 0.100 |
Why?
|
| Models, Molecular | 1 | 2016 | 1054 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 2190 | 0.100 |
Why?
|
| Disease Progression | 1 | 2018 | 2099 | 0.090 |
Why?
|
| Point Mutation | 1 | 2013 | 336 | 0.090 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2013 | 271 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 721 | 0.090 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 793 | 0.090 |
Why?
|
| Sequence Deletion | 1 | 2013 | 511 | 0.090 |
Why?
|
| Models, Biological | 1 | 2016 | 1370 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 987 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 1398 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 1494 | 0.080 |
Why?
|
| Mammary Glands, Animal | 1 | 2013 | 446 | 0.080 |
Why?
|
| Mice, Knockout | 1 | 2017 | 3706 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 1886 | 0.080 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 2544 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 1231 | 0.080 |
Why?
|
| Gene Expression | 1 | 2013 | 1485 | 0.070 |
Why?
|
| Cell Line | 1 | 2013 | 2565 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2017 | 2341 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2013 | 2902 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2020 | 1538 | 0.060 |
Why?
|
| Risk Factors | 1 | 2018 | 10397 | 0.050 |
Why?
|
| Leptin | 1 | 2022 | 218 | 0.040 |
Why?
|
| Glycolysis | 1 | 2019 | 167 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2019 | 708 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 222 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 477 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 930 | 0.030 |
Why?
|
| Tenascin | 1 | 2015 | 33 | 0.030 |
Why?
|
| Wnt1 Protein | 1 | 2015 | 74 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 2015 | 54 | 0.030 |
Why?
|
| Quinazolines | 1 | 2015 | 179 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2015 | 236 | 0.030 |
Why?
|
| Collagen | 1 | 2015 | 293 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2015 | 403 | 0.020 |
Why?
|
| Apoptosis | 1 | 2019 | 1805 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 1936 | 0.020 |
Why?
|
| Male | 1 | 2019 | 62089 | 0.010 |
Why?
|